首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.
【24h】

Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.

机译:内皮糖蛋白(CD105):其在血管生成以及肿瘤诊断,进展和治疗中的作用的综述。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Endoglin (CD105) is an accessory receptor for transforming growth factor beta (TGF-beta) and its expression is up-regulated in actively proliferating endothelial cells. Endoglin has been suggested as an appropriate marker for tumor-related angiogenesis and neovascularization. Several studies demonstrate the potential of endoglin in tumor diagnosis, prognosis, and therapy. This review details the structure and function of endoglin, and investigates the role of endoglin in angiogenesis and tumor diagnosis, prognosis, and therapy.
机译:内皮糖蛋白(CD105)是转化生长因子β(TGF-β)的辅助受体,其表达在活跃增殖的内皮细胞中上调。已建议使用内皮糖蛋白作为肿瘤相关血管生成和新血管形成的合适标志物。几项研究证明了内皮糖蛋白在肿瘤诊断,预后和治疗中的潜力。这篇综述详细介绍了内皮糖蛋白的结构和功能,并研究了内皮糖蛋白在血管生成,肿瘤诊断,预后和治疗中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号